Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/05/2022 | 43.85% | Morgan Stanley | → $66 | Assumes | → Overweight |
08/02/2022 | 15.52% | UBS | $50 → $53 | Maintains | Buy |
08/02/2022 | 37.31% | Goldman Sachs | $71 → $63 | Maintains | Buy |
08/02/2022 | 74.37% | Credit Suisse | $100 → $80 | Maintains | Outperform |
08/02/2022 | 17.7% | Piper Sandler | $50 → $54 | Maintains | Overweight |
07/22/2022 | 8.98% | UBS | $67 → $50 | Maintains | Buy |
07/18/2022 | 8.98% | Barclays | $64 → $50 | Maintains | Overweight |
07/18/2022 | 8.98% | Piper Sandler | $65 → $50 | Maintains | Overweight |
07/14/2022 | 43.85% | Morgan Stanley | $81 → $66 | Maintains | Overweight |
05/03/2022 | 63.47% | Stifel | $85 → $75 | Maintains | Buy |
05/03/2022 | 76.55% | Morgan Stanley | $87 → $81 | Maintains | Overweight |
05/03/2022 | 63.47% | Deutsche Bank | $80 → $75 | Maintains | Buy |
05/03/2022 | 39.49% | Barclays | $68 → $64 | Maintains | Overweight |
05/03/2022 | 41.67% | Raymond James | $70 → $65 | Maintains | Outperform |
05/03/2022 | 63.47% | RBC Capital | $85 → $75 | Maintains | Outperform |
05/03/2022 | 41.67% | Piper Sandler | $75 → $65 | Maintains | Overweight |
03/15/2022 | 52.57% | Wells Fargo | $80 → $70 | Maintains | Overweight |
02/16/2022 | 41.67% | Mizuho | $60 → $65 | Maintains | Buy |
02/16/2022 | 52.57% | Raymond James | $82 → $70 | Maintains | Outperform |
01/21/2022 | 74.37% | Deutsche Bank | $95 → $80 | Maintains | Buy |
11/16/2021 | 117.96% | Credit Suisse | → $100 | Initiates Coverage On | → Outperform |
11/02/2021 | — | UBS | Upgrades | Neutral → Buy | |
11/02/2021 | 85.27% | B of A Securities | $75 → $85 | Maintains | Buy |
11/02/2021 | 85.27% | Mizuho | $70 → $85 | Maintains | Buy |
11/02/2021 | 85.27% | RBC Capital | $70 → $85 | Maintains | Outperform |
11/02/2021 | 78.73% | Raymond James | $70 → $82 | Maintains | Outperform |
11/02/2021 | 87.45% | Barclays | $83 → $86 | Maintains | Overweight |
11/02/2021 | 91.8% | Piper Sandler | $72 → $88 | Maintains | Overweight |
10/26/2021 | 74.37% | Wells Fargo | $76 → $80 | Maintains | Overweight |
09/17/2021 | 80.91% | Barclays | $66 → $83 | Upgrades | Equal-Weight → Overweight |
08/16/2021 | 85.27% | Wolfe Research | $75 → $85 | Maintains | Outperform |
08/03/2021 | 63.47% | Wolfe Research | $70 → $75 | Maintains | Outperform |
08/03/2021 | 52.57% | Canaccord Genuity | $65 → $70 | Maintains | Buy |
08/03/2021 | 61.29% | Goldman Sachs | $65 → $74 | Maintains | Buy |
08/03/2021 | 74.37% | Truist Securities | $70 → $80 | Maintains | Buy |
08/03/2021 | 52.57% | RBC Capital | $60 → $70 | Maintains | Outperform |
08/03/2021 | 52.57% | Raymond James | $62 → $70 | Maintains | Outperform |
08/03/2021 | 43.85% | Barclays | $59 → $66 | Maintains | Equal-Weight |
08/03/2021 | 65.65% | Wells Fargo | $64 → $76 | Maintains | Overweight |
08/03/2021 | 52.57% | Mizuho | $63 → $70 | Maintains | Buy |
04/23/2021 | 30.78% | Wolfe Research | → $60 | Initiates Coverage On | → Outperform |
03/22/2021 | 41.67% | Goldman Sachs | → $65 | Initiates Coverage On | → Buy |
02/23/2021 | 52.57% | Piper Sandler | $59 → $70 | Maintains | Overweight |
02/23/2021 | 56.93% | Morgan Stanley | $55 → $72 | Maintains | Overweight |
02/23/2021 | 52.57% | Credit Suisse | $60 → $70 | Maintains | Outperform |
02/23/2021 | 35.14% | Raymond James | $56 → $62 | Maintains | Outperform |
12/22/2020 | 30.78% | Stephens & Co. | → $60 | Initiates Coverage On | → Overweight |
11/19/2020 | 15.52% | Morgan Stanley | → $53 | Upgrades | Equal-Weight → Overweight |
11/05/2020 | 8.98% | RBC Capital | → $50 | Upgrades | Sector Perform → Outperform |
09/24/2020 | 8.98% | Canaccord Genuity | → $50 | Upgrades | Hold → Buy |
09/23/2020 | 0.26% | Wells Fargo | → $46 | Upgrades | Equal-Weight → Overweight |
09/17/2020 | — | JP Morgan | Upgrades | Neutral → Overweight | |
07/20/2020 | 4.62% | Barclays | $54 → $48 | Maintains | Equal-Weight |
06/30/2020 | 8.98% | Deutsche Bank | → $50 | Initiates Coverage On | → Hold |
06/29/2020 | 19.88% | UBS | → $55 | Initiates Coverage On | → Neutral |
06/29/2020 | 30.78% | SunTrust Robinson Humphrey | → $60 | Initiates Coverage On | → Buy |
06/29/2020 | 8.98% | Morgan Stanley | → $50 | Initiates Coverage On | → Equal-Weight |
06/29/2020 | — | JMP Securities | Initiates Coverage On | → Market Perform | |
06/29/2020 | 8.98% | RBC Capital | → $50 | Initiates Coverage On | → Sector Perform |
06/29/2020 | — | Canaccord Genuity | Initiates Coverage On | → Hold | |
06/29/2020 | 19.88% | Wells Fargo | → $55 | Initiates Coverage On | → Equal-Weight |
06/29/2020 | 30.78% | B of A Securities | → $60 | Initiates Coverage On | → Buy |
06/29/2020 | 28.6% | Piper Sandler | → $59 | Initiates Coverage On | → Overweight |
06/29/2020 | 22.06% | Raymond James | → $56 | Initiates Coverage On | → Outperform |
06/29/2020 | 30.78% | Stifel | → $60 | Initiates Coverage On | → Buy |
ZoomInfo Technologies Questions & Answers
The latest price target for ZoomInfo Technologies (NASDAQ: ZI) was reported by Morgan Stanley on October 5, 2022. The analyst firm set a price target for $66.00 expecting ZI to rise to within 12 months (a possible 43.85% upside). 29 analyst firms have reported ratings in the last year.
The latest analyst rating for ZoomInfo Technologies (NASDAQ: ZI) was provided by Morgan Stanley, and ZoomInfo Technologies their overweight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ZoomInfo Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ZoomInfo Technologies was filed on October 5, 2022 so you should expect the next rating to be made available sometime around October 5, 2023.
While ratings are subjective and will change, the latest ZoomInfo Technologies (ZI) rating was a with a price target of $0.00 to $66.00. The current price ZoomInfo Technologies (ZI) is trading at is $45.88, which is within the analyst's predicted range.